Avid Bioservices Inc (CDMO)

[EndoTarget]

I must change for OncoTarget EndoTarget was way before.

This is HUGE.

Ca-125 can't screen women for early ovarian cancer, a deadly disease unnoticed until too late most of the time.

This new test will change women life for ever.

You do a blood test every 2 years. The test come back positive then you remove ovaries before growing or spreading.

MASSIVE.
Finally something marketable.

The good and easy thing is you test heathy women and you test women with known ovarian cancer. In one side you have nearly zero and on the other side 20. Bingo.

Make Peregrine great again!